• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌罗伊氏乳杆菌生物膜可产生抗菌和抗炎因子。

Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors.

作者信息

Jones Sara E, Versalovic James

机构信息

Department of Pathology, Baylor College of Medicine, Houston, Texas 77030, USA.

出版信息

BMC Microbiol. 2009 Feb 11;9:35. doi: 10.1186/1471-2180-9-35.

DOI:10.1186/1471-2180-9-35
PMID:19210794
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2653509/
Abstract

BACKGROUND

Commensal-derived probiotic bacteria inhibit enteric pathogens and regulate host immune responses in the gastrointestinal tract, but studies examining specific functions of beneficial microbes in the context of biofilms have been limited in scope.

RESULTS

Lactobacillus reuteri formed biofilms that retained functions potentially advantageous to the host including modulation of cytokine output and the production of the antimicrobial agent, reuterin. Immunomodulatory activities of biofilms were demonstrated by the abilities of specific L. reuteri strains to suppress human TNF production by LPS-activated monocytoid cells. Quantification of the antimicrobial glycerol derivative, reuterin, was assessed in order to document the antipathogenic potential of probiotic biofilms. L. reuteri biofilms differed in the quantities of reuterin secreted in this physiological state.

CONCLUSION

L. reuteri biofilms secreted factors that confer specific health benefits such as immunomodulation and pathogen inhibition. Future probiotic selection strategies should consider a strain's ability to perform beneficial functions as a biofilm.

摘要

背景

共生来源的益生菌可抑制肠道病原体并调节胃肠道中的宿主免疫反应,但在生物膜背景下研究有益微生物特定功能的研究范围有限。

结果

罗伊氏乳杆菌形成的生物膜保留了对宿主可能有利的功能,包括调节细胞因子输出和产生抗菌剂罗伊氏菌素。特定罗伊氏乳杆菌菌株抑制脂多糖激活的单核细胞样细胞产生人肿瘤坏死因子的能力证明了生物膜的免疫调节活性。为了记录益生菌生物膜的抗病原体潜力,对抗菌甘油衍生物罗伊氏菌素进行了定量分析。罗伊氏乳杆菌生物膜在这种生理状态下分泌的罗伊氏菌素数量有所不同。

结论

罗伊氏乳杆菌生物膜分泌的因子具有免疫调节和病原体抑制等特定的健康益处。未来的益生菌选择策略应考虑菌株作为生物膜发挥有益功能的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/153b/2653509/de2b6f1fc491/1471-2180-9-35-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/153b/2653509/a42832ab27e6/1471-2180-9-35-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/153b/2653509/fc82a082ba09/1471-2180-9-35-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/153b/2653509/07378144872d/1471-2180-9-35-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/153b/2653509/aa7953704941/1471-2180-9-35-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/153b/2653509/848d15f7abcc/1471-2180-9-35-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/153b/2653509/de2b6f1fc491/1471-2180-9-35-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/153b/2653509/a42832ab27e6/1471-2180-9-35-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/153b/2653509/fc82a082ba09/1471-2180-9-35-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/153b/2653509/07378144872d/1471-2180-9-35-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/153b/2653509/aa7953704941/1471-2180-9-35-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/153b/2653509/848d15f7abcc/1471-2180-9-35-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/153b/2653509/de2b6f1fc491/1471-2180-9-35-6.jpg

相似文献

1
Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors.益生菌罗伊氏乳杆菌生物膜可产生抗菌和抗炎因子。
BMC Microbiol. 2009 Feb 11;9:35. doi: 10.1186/1471-2180-9-35.
2
Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens.源自人类的益生菌罗伊氏乳杆菌表现出针对多种肠道细菌病原体的抗菌活性。
Anaerobe. 2008 Jun;14(3):166-71. doi: 10.1016/j.anaerobe.2008.02.001. Epub 2008 Feb 29.
3
Next-Generation Probiotics Targeting Clostridium difficile through Precursor-Directed Antimicrobial Biosynthesis.通过前体导向抗菌生物合成靶向艰难梭菌的下一代益生菌。
Infect Immun. 2017 Sep 20;85(10). doi: 10.1128/IAI.00303-17. Print 2017 Oct.
4
Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria.罗伊氏乳杆菌产生的罗伊氏菌素对肠道细菌的抑制活性谱。
BMC Microbiol. 2007 Nov 12;7:101. doi: 10.1186/1471-2180-7-101.
5
Evaluation of reuterin production in urogenital probiotic Lactobacillus reuteri RC-14.泌尿生殖系统益生菌罗伊氏乳杆菌RC-14中产罗伊氏菌素的评估。
Appl Environ Microbiol. 2008 Aug;74(15):4645-9. doi: 10.1128/AEM.00139-08. Epub 2008 Jun 6.
6
The antimicrobial compound reuterin (3-hydroxypropionaldehyde) induces oxidative stress via interaction with thiol groups.抗菌化合物雷菌醇(3-羟基丙醛)通过与巯基相互作用诱导氧化应激。
Microbiology (Reading). 2010 Jun;156(Pt 6):1589-1599. doi: 10.1099/mic.0.035642-0. Epub 2010 Feb 11.
7
Glycerol strengthens probiotic effect of Limosilactobacillus reuteri in oral biofilms: A synergistic synbiotic approach.甘油增强罗伊氏乳杆菌在口腔生物膜中的益生菌作用:协同共生方法。
Mol Oral Microbiol. 2022 Dec;37(6):266-275. doi: 10.1111/omi.12386. Epub 2022 Sep 22.
8
Comparative genome analysis of Lactobacillus reuteri and Lactobacillus fermentum reveal a genomic island for reuterin and cobalamin production.罗伊氏乳杆菌和发酵乳杆菌的比较基因组分析揭示了一个用于产生罗伊氏菌素和钴胺素的基因组岛。
DNA Res. 2008 Jun 30;15(3):151-61. doi: 10.1093/dnares/dsn009. Epub 2008 May 16.
9
Probiotic and Functional Properties of INIA P572.INIA P572的益生菌特性及功能特性
Nutrients. 2021 May 29;13(6):1860. doi: 10.3390/nu13061860.
10
Reuterin isolated from the probiotic Lactobacillus reuteri promotes periodontal tissue regeneration by inhibiting Cx43-mediated the intercellular transmission of endoplasmic reticulum stress.从益生菌乳杆菌中分离得到的雷替辛通过抑制 Cx43 介导的内质网应激的细胞间传递促进牙周组织再生。
J Periodontal Res. 2024 Jun;59(3):552-564. doi: 10.1111/jre.13233. Epub 2024 Jan 9.

引用本文的文献

1
Clinical and microbiological effectiveness of limosilactobacillus reuteri in supportive periodontal therapy: randomized clinical trial.罗伊氏乳杆菌在支持性牙周治疗中的临床及微生物学疗效:随机临床试验
Clin Oral Investig. 2025 Aug 26;29(9):422. doi: 10.1007/s00784-025-06508-w.
2
Genetically-programmed Hypervesiculation of Increases Production of Bacterial Extracellular Vesicles with Therapeutic Efficacy in a Preclinical Inflammatory Bowel Disease Model.基因编程的高囊泡化增加细菌细胞外囊泡的产生,在临床前炎症性肠病模型中具有治疗效果。
bioRxiv. 2025 Jun 25:2025.06.20.660770. doi: 10.1101/2025.06.20.660770.
3
The impact of Limosilactobacillus reuteri in combination with non-surgical periodontal therapy on periodontal clinical parameters and salivary and subgingival microbiota composition in individuals with stage III-IV periodontitis: a randomized controlled trial.

本文引用的文献

1
Microbial biofilm communities in the gastrointestinal tract.胃肠道中的微生物生物膜群落。
J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 1:S142-3. doi: 10.1097/MCG.0b013e31816207df.
2
Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun.益生菌罗伊氏乳杆菌通过c-Jun抑制促炎细胞因子。
Inflamm Bowel Dis. 2008 Aug;14(8):1068-83. doi: 10.1002/ibd.20448.
3
Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens.源自人类的益生菌罗伊氏乳杆菌表现出针对多种肠道细菌病原体的抗菌活性。
罗伊氏乳杆菌联合非手术牙周治疗对III-IV期牙周炎患者牙周临床参数、唾液及龈下微生物群组成的影响:一项随机对照试验
BMC Oral Health. 2025 May 22;25(1):759. doi: 10.1186/s12903-025-06084-1.
4
Glutamate Supplementation Regulates Nitrogen Metabolism in the Colon and Liver of Weaned Rats Fed a Low-Protein Diet.补充谷氨酸可调节低蛋白饮食断奶大鼠结肠和肝脏中的氮代谢。
Nutrients. 2025 Apr 26;17(9):1465. doi: 10.3390/nu17091465.
5
Probiotics and prebiotics: new treatment strategies for oral potentially malignant disorders and gastrointestinal precancerous lesions.益生菌与益生元:口腔潜在恶性疾病及胃肠道癌前病变的新治疗策略
NPJ Biofilms Microbiomes. 2025 Apr 8;11(1):55. doi: 10.1038/s41522-025-00688-9.
6
Dietary Qiwenghuangbo powder-enriched Limosilactobacillus reuteri protects the intestinal epithelium and alleviates inflammation via a strain-specific mechanism.富含奇文黄柏粉的罗伊氏乳杆菌通过菌株特异性机制保护肠上皮并减轻炎症。
Animal Model Exp Med. 2025 Jun;8(6):990-1003. doi: 10.1002/ame2.70016. Epub 2025 Mar 20.
7
Limosilactobacillus reuteri promotes the expression and secretion of enteroendocrine- and enterocyte-derived hormones.罗伊氏乳杆菌促进肠内分泌细胞和肠上皮细胞衍生激素的表达与分泌。
FASEB J. 2025 Mar 31;39(6):e70408. doi: 10.1096/fj.202401669R.
8
Study of the Effect of Synbiotic Diet on Haematological and Oxidative Indexes Changes in Male Dogs.合生元饮食对雄性犬血液学和氧化指标变化的影响研究
Vet Med Sci. 2025 Mar;11(2):e70290. doi: 10.1002/vms3.70290.
9
Modulatory Effect of Probiotic Fiber (Lactobacillus reuteri) in Residual Periodontal Pockets: A Randomized, Double-Blind, Placebo-Controlled Study.益生菌纤维(罗伊氏乳杆菌)对残余牙周袋的调节作用:一项随机、双盲、安慰剂对照研究。
Cureus. 2025 Jan 14;17(1):e77413. doi: 10.7759/cureus.77413. eCollection 2025 Jan.
10
The Impact of on Oral and Systemic Health: A Comprehensive Review of Recent Research.关于[具体内容缺失]对口腔和全身健康的影响:近期研究的综合综述。
Microorganisms. 2024 Dec 30;13(1):45. doi: 10.3390/microorganisms13010045.
Anaerobe. 2008 Jun;14(3):166-71. doi: 10.1016/j.anaerobe.2008.02.001. Epub 2008 Feb 29.
4
Glycerol induces reuterin production and decreases Escherichia coli population in an in vitro model of colonic fermentation with immobilized human feces.在固定化人粪便的结肠发酵体外模型中,甘油可诱导罗伊氏乳杆菌素的产生并减少大肠杆菌数量。
FEMS Microbiol Ecol. 2008 Jan;63(1):56-64. doi: 10.1111/j.1574-6941.2007.00412.x. Epub 2007 Nov 20.
5
Biofilms in the normal human large bowel: fact rather than fiction.正常人大肠中的生物膜:事实而非虚构。
Gut. 2007 Oct;56(10):1481-2.
6
Lactobacillus reuteri tablets suppress Helicobacter pylori infection--a double-blind randomised placebo-controlled cross-over clinical study.罗伊氏乳杆菌片抑制幽门螺杆菌感染——一项双盲随机安慰剂对照交叉临床研究。
Kansenshogaku Zasshi. 2007 Jul;81(4):387-93. doi: 10.11150/kansenshogakuzasshi1970.81.387.
7
D-alanyl ester depletion of teichoic acids in Lactobacillus reuteri 100-23 results in impaired colonization of the mouse gastrointestinal tract.罗伊氏乳杆菌100-23中磷壁酸的D-丙氨酰酯消耗导致其在小鼠胃肠道中的定殖受损。
Environ Microbiol. 2007 Jul;9(7):1750-60. doi: 10.1111/j.1462-2920.2007.01292.x.
8
Viscosity gradient within the mucus layer determines the mucosal barrier function and the spatial organization of the intestinal microbiota.黏液层内的黏度梯度决定了黏膜屏障功能以及肠道微生物群的空间组织。
Inflamm Bowel Dis. 2007 Aug;13(8):963-70. doi: 10.1002/ibd.20163.
9
Microbial biofilms in the human gastrointestinal tract.人类胃肠道中的微生物生物膜
J Appl Microbiol. 2007 May;102(5):1187-96. doi: 10.1111/j.1365-2672.2007.03287.x.
10
Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial.益生菌预防IgE相关湿疹:一项双盲、随机、安慰剂对照试验。
J Allergy Clin Immunol. 2007 May;119(5):1174-80. doi: 10.1016/j.jaci.2007.01.007. Epub 2007 Mar 8.